DFFVX
Price
$39.06
Change
+$0.24 (+0.62%)
Updated
Jan 14 closing price
Net Assets
14.62B
RYMVX
Price
$81.07
Change
+$0.49 (+0.61%)
Updated
Jan 14 closing price
Net Assets
6.02M
Interact to see
Advertisement

DFFVX vs RYMVX

Header iconDFFVX vs RYMVX Comparison
Open Charts DFFVX vs RYMVXBanner chart's image
DFA US Targeted Value I
Price$39.06
Change+$0.24 (+0.62%)
VolumeN/A
Net Assets14.62B
Rydex S&P MidCap 400 Pure Value A
Price$81.07
Change+$0.49 (+0.61%)
VolumeN/A
Net Assets6.02M
DFFVX vs RYMVX Comparison Chart in %
View a ticker or compare two or three
VS
DFFVX vs. RYMVX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Hold and RYMVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 14.6B vs. RYMVX (6.02M). DFFVX pays higher dividends than RYMVX: DFFVX (1.69) vs RYMVX (0.14). DFFVX was incepted earlier than RYMVX: DFFVX (26 years) vs RYMVX (21 years). RYMVX (1.60) is less costly to investors than DFFVX (0.30). RYMVX is a more actively managed with annual turnover of: 3996.00 vs. DFFVX (7.00). DFFVX has a lower initial minimum investment than RYMVX: DFFVX (0) vs RYMVX (2500). DFFVX annual gain was more profitable for investors over the last year : 14.93 vs. RYMVX (8.91). DFFVX return over 5 years is better than : 62.53 vs. RYMVX (35.37).
DFFVXRYMVXDFFVX / RYMVX
Total Expense Ratio0.291.5519%
Annual Report Gross Expense Ratio0.301.6019%
Fund Existence26 years21 years-
Gain YTD5.6254.850116%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets14.6B6.02M242,606%
Annual Yield % from dividends1.690.141,170%
Returns for 1 year14.938.91167%
Returns for 3 years40.3525.37159%
Returns for 5 years62.5335.37177%
Returns for 10 years137.45138.3899%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABAT5.310.41
+8.37%
American Battery Technology Company
LH262.008.02
+3.16%
Laboratory Corp
CLDI1.120.02
+1.82%
Calidi Biotherapeutics
GTM10.080.02
+0.20%
ZOOMINFO Technologies Inc.
FGNX3.24N/A
N/A
FG Nexus Inc.